Celecoxib most cost-effective choice in high-risk arthritis patients

Source: Inpharma, Volume 1, Numbers 1480-1481, 2005-03-26 , pp. 4-4(1)

Publisher: Adis International

Keywords: Celecoxib, adverse reactions; Cost-effectiveness; Cost-utility; Gastrointestinal-disorders, drug-induced; Nonsteroidal-anti-inflammatories, adverse reaction; Rofecoxib, adverse reactions

Document Type: Research article

Publication date: 2005-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers